Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea
· Delayed Price · Currency is KRW 4,325.00
+30.00 (0.70%)
At close: Dec 5, 2025
Genesystem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Operating Revenue | 345.38 | 1,208 | 897.03 | 3,653 |
| Other Revenue | - | 0 | 0 | - |
| Revenue | 345.38 | 1,208 | 897.03 | 3,653 |
| Revenue Growth (YoY) | -70.01% | 34.64% | -75.44% | - |
| Cost of Revenue | 2,578 | 3,028 | 2,483 | 2,486 |
| Gross Profit | -2,233 | -1,820 | -1,586 | 1,167 |
| Selling, General & Admin | 3,701 | 3,885 | 4,119 | 3,855 |
| Research & Development | 2,907 | 3,344 | 3,425 | 3,354 |
| Amortization of Goodwill & Intangibles | 771.44 | 776.44 | 196.51 | 73.49 |
| Other Operating Expenses | 100.86 | 85.56 | 76.6 | 72.81 |
| Operating Expenses | 7,703 | 8,296 | 7,898 | 7,772 |
| Operating Income | -9,936 | -10,116 | -9,484 | -6,605 |
| Interest Expense | -126.56 | -136.25 | -133.61 | -95.47 |
| Interest & Investment Income | 120.29 | 300.54 | 363.75 | 205.31 |
| Earnings From Equity Investments | - | - | 882.76 | - |
| Currency Exchange Gain (Loss) | 22.97 | 70.28 | 76.04 | 234.36 |
| Other Non Operating Income (Expenses) | 23.44 | 7.12 | 124.59 | 29.27 |
| EBT Excluding Unusual Items | -9,896 | -9,874 | -8,171 | -6,231 |
| Gain (Loss) on Sale of Investments | 166.01 | 194.97 | 258.36 | -825.27 |
| Gain (Loss) on Sale of Assets | - | -0.18 | - | -3.14 |
| Pretax Income | -9,730 | -9,679 | -7,913 | -7,060 |
| Income Tax Expense | -153.36 | -150.73 | 146.41 | 1,936 |
| Earnings From Continuing Operations | -9,577 | -9,529 | -8,059 | -8,996 |
| Minority Interest in Earnings | 633.56 | 613.41 | 143.55 | - |
| Net Income | -8,943 | -8,915 | -7,915 | -8,996 |
| Net Income to Common | -8,943 | -8,915 | -7,915 | -8,996 |
| Shares Outstanding (Basic) | 7 | 7 | 7 | 7 |
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 |
| Shares Change (YoY) | -1.17% | -1.50% | 0.69% | - |
| EPS (Basic) | -1313.13 | -1302.43 | -1139.05 | -1303.50 |
| EPS (Diluted) | -1313.13 | -1302.43 | -1139.05 | -1303.50 |
| Free Cash Flow | -7,608 | -7,595 | -8,174 | -6,655 |
| Free Cash Flow Per Share | -1117.08 | -1109.62 | -1176.31 | -964.32 |
| Gross Margin | - | -150.69% | -176.81% | 31.96% |
| Operating Margin | -2876.83% | -837.58% | -1057.33% | -180.80% |
| Profit Margin | -2589.31% | -738.17% | -882.41% | -246.26% |
| Free Cash Flow Margin | -2202.73% | -628.89% | -911.27% | -182.18% |
| EBITDA | -8,707 | -8,873 | -8,939 | -6,219 |
| EBITDA Margin | - | - | - | -170.23% |
| D&A For EBITDA | 1,229 | 1,242 | 545.39 | 386.3 |
| EBIT | -9,936 | -10,116 | -9,484 | -6,605 |
| EBIT Margin | - | - | - | -180.80% |
| Advertising Expenses | - | 182.95 | 281.68 | 239.36 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.